Evidence map›Paper›PMID 32013999›Full record

ArticleWorld journal of surgical oncology2020

MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.

Qingli Huang, Sen Hou, Xiuqing Zhu, Shouzhou Liu

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qingli HuangDepartment of Otorhinolaryngology Head and Neck Surgery, Liaocheng People's Hospital, No.67 Dongchang West Road, Liaocheng, 252000, Shandong Province, People's Republic of China.
Sen HouDepartment of Otolaryngology, Yanggu People's Hospital, Liaocheng, Shandong Province, People's Republic of China.
Xiuqing ZhuDepartment of Otolaryngology, Chiping People's Hospital, Liaocheng, Shandong Province, People's Republic of China.
Shouzhou LiuDepartment of Otorhinolaryngology Head and Neck Surgery, Liaocheng People's Hospital, No.67 Dongchang West Road, Liaocheng, 252000, Shandong Province, People's Republic of China. juzhiwei54539@163.com.
Liaocheng People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe dysregulation of microRNAs (miRNAs) has been found in diseases and cancers, including microRNA-192 (miR-192). This study was designed to investigate the role of miR-192 in nasopharyngeal carcinoma (NPC) progression.

methodsThe expression levels of miR-192 and some genes were assessed by qRT-PCR and Western blot. The function of miR-192 was investigated through MTT, Transwell, and dual-luciferase reporter assays.

resultsThe expression of miR-192 was increased in NPC tissues, and high miR-192 expression predicted poor prognosis in NPC patients. Functionally, upregulation of miR-192 promoted NPC cell migration, invasion, and growth. Furthermore, miR-192 activated EMT and PI3K/AKT pathway to regulate NPC progression. In addition, miR-192 directly targeted RB1 and suppressed its expression in NPC. Moreover, overexpression of RB1 weakened the promoted effect of miR-192 in NPC.

conclusionmiR-192 promoted cell viability and metastasis in NPC through suppressing RB1 expression and activating PI3K/AKT pathway.

Indexed as

ApoptosisBiomarkers, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionFemaleFollow-Up StudiesGene Expression Regulation, NeoplasticHumansMaleMicroRNAsMiddle AgedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPhosphatidylinositol 3-KinasesPrognosisBiomarkers, TumorMicroRNAsMIRN192 microRNA, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRB1 protein, humanRetinoblastoma Binding ProteinsUbiquitin-Protein LigasesmiR-192Nasopharyngeal carcinomaPI3K/AKT pathwayRB1

Identifiers

PMID32013999
PMCPMC6998165
OpenAlexW3007094830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.